Eladl E - Search Results

1

Molecular characterization of AML-MRC reveals TP53 mutation as an adverse prognostic factor irrespective of MRC-defining criteria, TP53 allelic state, or TP53 variant allele frequency.

Zhao D, Eladl E, Zarif M, Capo-Chichi JM, Schuh A, Atenafu E, Minden M, Chang H. Zhao D, et al. Among authors: eladl e. Cancer Med. 2023 Mar;12(6):6511-6522. doi: 10.1002/cam4.5421. Epub 2022 Nov 16. Cancer Med. 2023. PMID: 36394085 Free PMC article.

2

Role of CD47 in Hematological Malignancies.

Eladl E, Tremblay-LeMay R, Rastgoo N, Musani R, Chen W, Liu A, Chang H. Eladl E, et al. J Hematol Oncol. 2020 Jul 16;13(1):96. doi: 10.1186/s13045-020-00930-1. J Hematol Oncol. 2020. PMID: 32677994 Free PMC article. Review.

3

Bone marrow infiltration by plasmablastic neoplasm: plasmablastic myeloma or plasmablastic lymphoma?

Eladl E, Chang H. Eladl E, et al. Blood. 2021 Mar 4;137(9):1268. doi: 10.1182/blood.2020009735. Blood. 2021. PMID: 33661296 Free article. No abstract available.

4

Multiple Auer rods in a mixed-phenotype acute leukemia.

Chang H, Eladl E. Chang H, et al. Among authors: eladl e. Blood. 2021 Mar 25;137(12):1702. doi: 10.1182/blood.2020010470. Blood. 2021. PMID: 33764432 Free article. No abstract available.

5

NPM1-mutated AML-MRC diagnosed on the basis of history of MDS or MDS/MPN frequently harbours secondary-type mutations and confers inferior outcome compared to AML with mutated NPM1.

Zhao D, Zarif M, Eladl E, Capo-Chichi JM, Smith AC, Atenafu EG, Tierens A, Minden MD, Schuh A, Chang H. Zhao D, et al. Among authors: eladl e. Leuk Res. 2022 Jul;118:106869. doi: 10.1016/j.leukres.2022.106869. Epub 2022 May 22. Leuk Res. 2022. PMID: 35636054

6

Mixed-phenotype acute leukemia with a predominant B/T and a small subset of myeloid lineage expression.

Pourabdollah M, Eladl E, Liu A, Chang H. Pourabdollah M, et al. Among authors: eladl e. EJHaem. 2020 Oct 16;1(2):402-403. doi: 10.1002/jha2.107. eCollection 2020 Nov. EJHaem. 2020. PMID: 35844996 Free PMC article. No abstract available.

7

Molecular genetic characterization of Philadelphia chromosome-positive acute myeloid leukemia.

Zhou Q, Zhao D, Eladl E, Capo-Chichi JM, Kim DDH, Chang H. Zhou Q, et al. Among authors: eladl e. Leuk Res. 2023 Jan;124:107002. doi: 10.1016/j.leukres.2022.107002. Epub 2022 Dec 16. Leuk Res. 2023. PMID: 36563650

8

AML with CEBPA mutations: A comparison of ICC and WHO-HAEM5 criteria in patients with 20% or more blasts.

Zhao D, Zhou Q, Zarif M, Eladl E, Wei C, Atenafu EG, Schuh A, Tierens A, Yeung YWT, Minden MD, Chang H. Zhao D, et al. Among authors: eladl e. Leuk Res. 2023 Nov;134:107376. doi: 10.1016/j.leukres.2023.107376. Epub 2023 Aug 29. Leuk Res. 2023. PMID: 37690321

9

Prognostic Value of BRAF, Programmed Cell Death 1 (PD1), and PD Ligand 1 (PDL1) Protein Expression in Colon Adenocarcinoma.

Ibrahiem AT, Eladl E, Toraih EA, Fawzy MS, Abdelwahab K, Elnaghi K, Emarah Z, Shaalan AAM, Ehab Z, Soliman NA. Ibrahiem AT, et al. Among authors: eladl e. Diagnostics (Basel). 2023 Jan 9;13(2):237. doi: 10.3390/diagnostics13020237. Diagnostics (Basel). 2023. PMID: 36673047 Free PMC article.

10

Antiangiogenic activity of vitexicarpine in experimentally induced hepatocellular carcinoma: Impact on vascular endothelial growth factor pathway.

Hassoun SM, Abdel-Rahman N, Eladl EI, El-Shishtawy MM. Hassoun SM, et al. Tumour Biol. 2017 Jun;39(6):1010428317707376. doi: 10.1177/1010428317707376. Tumour Biol. 2017. PMID: 28651490 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12 results

Search Page

Filters